These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 35093510)

  • 1. The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial.
    Varnasseri M; Siahpoosh A; Hoseinynejad K; Amini F; Karamian M; Yad MJY; Cheraghian B; Khosravi AD
    Complement Ther Med; 2022 May; 65():102808. PubMed ID: 35093510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial.
    Karkon Varnosfaderani S; Hashem-Dabaghian F; Amin G; Bozorgi M; Heydarirad G; Nazem E; Nasiri Toosi M; Mosavat SH
    J Integr Med; 2018 Mar; 16(2):126-131. PubMed ID: 29526236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of an oral product containing Amla fruit (Phyllanthus emblica L.) on female androgenetic alopecia: A randomized controlled trial.
    Akhbari M; Firooz A; Rahimi R; Shirzad M; Esmaealzadeh N; Shirbeigi L
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116958. PubMed ID: 37487962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive and pleiotropic effects of Phyllanthus emblica extract as an add-on therapy in patients with essential hypertension-A randomized double-blind placebo-controlled trial.
    Shanmugarajan D; Girish C; Harivenkatesh N; Chanaveerappa B; Prasanna Lakshmi NC
    Phytother Res; 2021 Jun; 35(6):3275-3285. PubMed ID: 33570228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia.
    Upadya H; Prabhu S; Prasad A; Subramanian D; Gupta S; Goel A
    BMC Complement Altern Med; 2019 Jan; 19(1):27. PubMed ID: 30670010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study.
    Usharani P; Merugu PL; Nutalapati C
    BMC Complement Altern Med; 2019 May; 19(1):97. PubMed ID: 31060549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-blind controlled trial.
    Adel Mehraban MS; Shirzad M; Mohammad Taghizadeh Kashani L; Ahmadian-Attari MM; Safari AA; Ansari N; Hatami H; Kamalinejad M
    J Ethnopharmacol; 2023 Mar; 304():116058. PubMed ID: 36535329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial.
    Honarkar Shafie E; Taheri F; Alijani N; Okhovvat AR; Goudarzi R; Borumandnia N; Aghaghazvini L; Rezayat SM; Jamalimoghadamsiahkali S; Hosseinzadeh-Attar MJ
    Phytother Res; 2022 Feb; 36(2):1013-1022. PubMed ID: 35023260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of the chest CT score in COVID-19 patients: a cross-sectional study.
    Yazdi NA; Ghadery AH; SeyedAlinaghi S; Jafari F; Jafari S; Hasannezad M; Koochak HE; Salehi M; Manshadi SAD; Meidani M; Hajiabdolbaghi M; Ahmadinejad Z; Khalili H; Mehrabi Nejad MM; Abbasian L
    Virol J; 2021 Nov; 18(1):225. PubMed ID: 34794467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative therapeutic efficacy of Phyllanthus emblica (Amla) fruit extract and procaine penicillin in the treatment of subclinical mastitis in dairy buffaloes.
    Khan A; Ahmed T; Rizwan M; Khan N
    Microb Pathog; 2018 Feb; 115():8-11. PubMed ID: 29253597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effect of silver nanoparticles synthesized using amla on Hep2 cell line.
    Rosarin FS; Arulmozhi V; Nagarajan S; Mirunalini S
    Asian Pac J Trop Med; 2013 Jan; 6(1):1-10. PubMed ID: 23317879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study.
    Usharani P; Fatima N; Muralidhar N
    Diabetes Metab Syndr Obes; 2013; 6():275-84. PubMed ID: 23935377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of clinical, laboratory and chest CT findings of laboratory-confirmed and clinically diagnosed COVID-19 patients at first admission.
    Kuzan TY; Murzoğlu Altıntoprak K; Çiftçi HÖ; Ergül U; Ünal Özdemir NB; Bulut M; Yiyit N
    Diagn Interv Radiol; 2021 May; 27(3):336-343. PubMed ID: 32876570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Characteristics of Mild-Moderate COVID-19 Patients and Risk Factors for the Development of Pneumonia].
    Özdemir YE; Balkan İİ; Bayramlar OF; Alkan S; Murt A; Karaali R; Mete B; Kuşkucu MA; Aygün G; Keskindemirci Y; Öngören Ş; Kutlubay Z; Çetinkale O; Saltoğlu N; Tabak F
    Mikrobiyol Bul; 2021 Jul; 55(3):342-356. PubMed ID: 34416801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral intake of lingonberry and amla fruit extract improves skin conditions in healthy female subjects: A randomized, double-blind, placebo-controlled clinical trial.
    Uchiyama T; Tsunenaga M; Miyanaga M; Ueda O; Ogo M
    Biotechnol Appl Biochem; 2019 Sep; 66(5):870-879. PubMed ID: 31342566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the Unani Regimen as an Add-On to Standard Treatment in Hospitalised RT-PCR-Confirmed Mild to Moderate COVID-19 Patients: An Open-Label Randomized Controlled Trial.
    Kishore J; Kumar R; Nazli T; Ahmad A; Kumar P; Khan AA
    Cureus; 2023 May; 15(5):e38574. PubMed ID: 37284399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial.
    Mosadegh M; Khalkhali A; Erfani Y; Nezamdoost M
    Microb Pathog; 2022 Nov; 172():105792. PubMed ID: 36165862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on degradation kinetics of ascorbic acid in amla (Phyllanthus emblica L.) during cooking.
    Nisha P; Singhal RS; Pandit AB
    Int J Food Sci Nutr; 2004 Aug; 55(5):415-22. PubMed ID: 15545050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic Analysis and Antioxidant Effect of Amla (Emblica officinalis) Extract in Preventing Oxidative Stress-Induced Red Cell Damage and Plasma Protein Alterations: An In Vitro Study.
    Packirisamy RM; Bobby Z; Panneerselvam S; Koshy SM; Jacob SE
    J Med Food; 2018 Jan; 21(1):81-89. PubMed ID: 29064307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.